UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Obesity: Current and potential pharmacotherapeutics and targets

Pharmacology & therapeutics (Oxford), 2017-02, Vol.170, p.116-147

2017

Volltextzugriff (PDF)

Pharmacology biochemistry and behavior: Personal perspectives from 50 years ago

Pharmacology, biochemistry and behavior, 2024-04, Vol.237, p.173739-173739, Article 173739

2024

Volltextzugriff (PDF)

INNOVATOR SYMPOSIUM: MEDICATION DEVELOPMENT FOR METHAMPHETAMINE USE DISORDER

Drug and alcohol dependence, 2024-07, Vol.260, p.110788, Article 110788

Dwoskin, Linda

2024

Volltextzugriff (PDF)

10:00 A.M. - 11:30 A.M - INNOVATOR SYMPOSIUM: MEDICATION DEVELOPMENT FOR METHAMPHETAMINE USE DISORDER: Plaza Ballroom A

Drug and alcohol dependence, 2024-07, Vol.260

Dwoskin, Linda

2024

Volltextzugriff (PDF)

Effect of environmental enrichment on dopamine and serotonin transporters and glutamate neurotransmission in medial prefrontal and orbitofrontal cortex

Brain research, 2015-03, Vol.1599, p.115-125

2015

Volltextzugriff (PDF)

Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats

Biochemical pharmacology, 2024-10, Vol.228, p.116189, Article 116189

2024

Volltextzugriff (PDF)

Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse

Advances in Pharmacology, 2014, Vol.69, p.513-551

2014

Volltextzugriff (PDF)

The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse

Advances in pharmacology (1990), 2014, Vol.69, p.71-106

2014

Volltextzugriff (PDF)

Efficient synthesis of cis-2,6-di-(2-quinolylpiperidine)

Tetrahedron letters, 2013-09, Vol.54 (38), p.5211-5213

2013

Volltextzugriff (PDF)

Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood

Psychopharmacology, 2016-12, Vol.233 (23-24), p.3891-3903

2016

Volltextzugriff (PDF)

Total Synthesis of Decahydroquinoline Poison Frog Alkaloids ent- cis -195A and cis -211A

Molecules (Basel, Switzerland), 2021-12, Vol.26 (24), p.7529

2021

Volltextzugriff (PDF)

Toward isolating reward changes in diet-induced obesity: A demand analysis

Physiology & behavior, 2020-01, Vol.213, p.112729, Article 112729

2020

Volltextzugriff (PDF)

A Comparative Effectiveness Study on Opioid Use Disorder Prediction Using Artificial Intelligence and Existing Risk Models

IEEE journal of biomedical and health informatics, 2023-07, Vol.27 (7), p.1-10

2023

Volltextzugriff (PDF)

Varenicline serves as the training stimulus in the drug-discriminated goal-tracking task with rats: initial evaluation of potential neuropharmacological processes

Behavioural pharmacology, 2023-02, Vol.34 (1), p.12-19

2023

Volltextzugriff (PDF)

Short-term CaMKII inhibition with tatCN19o does not erase pre-formed memory in mice and is neuroprotective in pigs

The Journal of biological chemistry, 2023-05, Vol.299 (5), p.104693-104693, Article 104693

2023

Volltextzugriff (PDF)

Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M 1 - M 5 muscarinic acetylcholine receptors

Bioorganic & medicinal chemistry letters, 2019-02, Vol.29 (3), p.471

2019

Volltextzugriff (PDF)

Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M1 – M5 muscarinic acetylcholine receptors

Bioorganic & medicinal chemistry letters, 2019-02, Vol.29 (3), p.471-476

2019

Volltextzugriff (PDF)

Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD

Pharmacology, biochemistry and behavior, 2016-06, Vol.145, p.24-26

2016

Volltextzugriff (PDF)

Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents

The Journal of neuroscience, 2015-02, Vol.35 (8), p.3625-3643

2015

Volltextzugriff (PDF)

GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine

The Journal of pharmacology and experimental therapeutics, 2019-11, Vol.371 (2), p.526-543

2019

Volltextzugriff (PDF)

Environmental enrichment reduces methamphetamine cue-induced reinstatement but does not alter methamphetamine reward or VMAT2 function

Behavioural brain research, 2014-08, Vol.270, p.151-158

2014

Volltextzugriff (PDF)

Methylphenidate Treatment in Adolescent Rats with an Attention Deficit Hyperactivity Disorder Phenotype: Cocaine Addiction Vulnerability and Dopamine Transporter Function

Neuropsychopharmacology (New York, N.Y.), 2011-03, Vol.36 (4), p.837-847

2011

Volltextzugriff (PDF)

Adolescent d-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood

Behavioural brain research, 2016-01, Vol.297, p.165-179

2016

Volltextzugriff (PDF)

Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: Dopamine transporter function and cellular distribution in adulthood

Biochemical pharmacology, 2013-07, Vol.86 (2), p.309-316

2013

Volltextzugriff (PDF)

Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [3H]dopamine and [3H]norepinephrine release

Biochemical pharmacology, 2013-09, Vol.86 (5), p.656-665

2013

Volltextzugriff (PDF)

1 – 25 von 305

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(250)

Publikationsform

Sprache

Englisch
(305)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Obesity: Current and potential pharmacotherapeutics and targets

Pharmacology biochemistry and behavior: Personal perspectives from 50 years ago

INNOVATOR SYMPOSIUM: MEDICATION DEVELOPMENT FOR METHAMPHETAMINE USE DISORDER

10:00 A.M. - 11:30 A.M - INNOVATOR SYMPOSIUM: MEDICATION DEVELOPMENT FOR METHAMPHETAMINE USE DISORDER: Plaza Ballroom A

Effect of environmental enrichment on dopamine and serotonin transporters and glutamate neurotransmission in medial prefrontal and orbitofrontal cortex

Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats

Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse

The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse

Efficient synthesis of cis-2,6-di-(2-quinolylpiperidine)

Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood

Total Synthesis of Decahydroquinoline Poison Frog Alkaloids ent- cis -195A and cis -211A

Toward isolating reward changes in diet-induced obesity: A demand analysis

A Comparative Effectiveness Study on Opioid Use Disorder Prediction Using Artificial Intelligence and Existing Risk Models

Varenicline serves as the training stimulus in the drug-discriminated goal-tracking task with rats: initial evaluation of potential neuropharmacological processes

Short-term CaMKII inhibition with tatCN19o does not erase pre-formed memory in mice and is neuroprotective in pigs

Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M 1 - M 5 muscarinic acetylcholine receptors

Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M1 – M5 muscarinic acetylcholine receptors

Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD

Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents

GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine

Environmental enrichment reduces methamphetamine cue-induced reinstatement but does not alter methamphetamine reward or VMAT2 function

Methylphenidate Treatment in Adolescent Rats with an Attention Deficit Hyperactivity Disorder Phenotype: Cocaine Addiction Vulnerability and Dopamine Transporter Function

Adolescent d-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood

Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: Dopamine transporter function and cellular distribution in adulthood

Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [3H]dopamine and [3H]norepinephrine release

Suchergebnisse filtern